CD4<sup>+</sup> T cells drive corneal nerve damage but not epitheliopathy in an acute aqueous-deficient dry eye model.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39560641.
- Also identified by DOI 10.1073/pnas.2407648121 and PMC identifier 11621630.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Dry eye disease (DED) is characterized by a dysfunctional tear film in which the corneal epithelium and its abundant nerves are affected by ocular desiccation and inflammation. Although adaptive immunity and specifically CD4<sup>+</sup> T cells play a role in DED pathogenesis, the exact contribution of these cells to corneal epithelial and neural damage remains undetermined. To address this, we explored the progression of a surgical DED model in wild-type (WT) and T cell-deficient mice. We observed that adaptive immune-deficient mice developed all aspects of DED comparably to WT mice except for the absence of functional and morphological corneal nerve changes, nerve damage-associated transcriptomic signature in the trigeminal ganglia, and sustained tear cytokine levels. Adoptive transfer of CD4<sup>+</sup> T cells from WT DED mice to T cell-deficient mice reproduced corneal nerve damage but not epitheliopathy. Conversely, T cell-deficient mice reconstituted solely with naïve CD4<sup>+</sup> T cells developed corneal nerve impairment and epitheliopathy upon DED induction, thus replicating the WT DED phenotype. Collectively, our data show that while corneal neuropathy is driven by CD4<sup>+</sup> T cells in DED, corneal epithelial damage develops independently of the adaptive immune response. These findings have implications for T cell-targeting therapies currently in use for DED.
Medical subject headings
- Dry Eye Syndromes
- CD4-Positive T-Lymphocytes
- Disease Models, Animal
- Epithelium, Corneal